Stock Report

Download full stock data and analysis for free Last Updated: 01-Oct-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Abbott India Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: ABBOTINDIA | BSE: 500488

₹26,840.00

up-down-arrow ₹-285.00 (-1.05%)

As on 01-Oct-2026IST

Market cap

info icon

₹57,016 Cr

Revenue (TTM)

info icon

₹7,004 Cr

P/E Ratio

info icon

35.3

P/B Ratio

info icon

11

Div. Yield

info icon

2.4 %

Edit peer-selector-edit
Abbott India Zydus Lifesciences Mankind Pharma Dr. Reddy'S Labs Aurobindo Pharma
Market cap (₹ Cr)
 57,016 1,14,239 1,04,376 1,00,170 96,376
Revenue (₹ Cr)
 7,004 28,592 14,738 33,228 34,935
Net Profit (₹ Cr)
 1,614.68 4,492.20 2,055.11 3,169.30 3,712.74
Net Margin (%)
 22.13 14.92 13.64 9.15 10.42
RoE (%)
 36.76 18.78 13.60 8.72 10.38
Price to Earnings
 35.31 25.31 51.10 31.09 25.96
Price-To-Book
 11.02 4.24 6.20 2.62 2.48

Income Statement (₹ Cr)

Abbott India Zydus Lifesciences Mankind Pharma Dr. Reddy'S Labs Aurobindo Pharma
Operating Revenue arrow
6,929.05 27,148.40 14,277.64 33,700.20 33,653.08
Total Income arrow
7,219.28 28,943.00 14,636.43 35,058.60 34,173.57
Total Expenditure arrow
5,039.06 19,958.40 10,655.26 27,246.70 26,835.75
EBITDA arrow
1,889.99 7,190.00 3,622.38 6,453.50 6,817.33
Depreciation arrow
75.96 1,408.00 886.18 2,058.80 1,778.19
EBIT arrow
1,814.03 5,782.00 2,736.20 4,394.70 5,039.14
Interest arrow
24.99 438.90 644.25 373.80 383.97
Other Income arrow
290.23 1,794.60 358.79 1,358.40 520.49
Exceptional Items arrow
-- -516.60 -129.75 -- -65.33
Profit before Tax arrow
2,079.27 6,621.10 2,332.68 5,392.70 5,111.85
Provision for Tax arrow
527.25 1,594.70 394.58 1,235.10 1,608.88
Profit after Tax arrow
1,552.02 5,026.40 1,938.10 4,157.60 3,502.97

Liabilities (₹ Cr)

Abbott India Zydus Lifesciences Mankind Pharma Dr. Reddy'S Labs Aurobindo Pharma
Shareholder's Funds arrow
4,774.19 27,111.40 16,300.34 37,891.50 37,890.97
Minority Interest arrow
-- 2,470.80 260.71 339.40 -8.16
Non-Current Liabilities arrow
225.20 5,003.90 4,686.53 926.10 1,096.74
Current Liabilities arrow
1,476.57 15,711.90 6,507.25 16,747.40 18,039.01
Total Liabilities arrow
6,501.93 50,672.60 27,754.83 56,576.70 58,196.15

Assets (₹ Cr)

Abbott India Zydus Lifesciences Mankind Pharma Dr. Reddy'S Labs Aurobindo Pharma
Non-Current Assets arrow
2,705.27 30,391.90 20,800.63 25,875.60 24,309.81
Current Assets arrow
3,770.69 19,906.10 6,951.50 30,028.80 32,708.75
Total Assets arrow
6,501.93 50,672.60 27,754.83 56,576.70 58,196.15
Total Debt* arrow
0.00 11,769.50 6,021.78 7,734.10 7,676.20
Net Current Assets arrow
2,294.12 4,194.20 444.25 13,281.40 14,669.74
Contingent Liabilities arrow
114.18 989.90 924.77 336.14 1,358.37

Cashflow (₹ Cr)

Abbott India Zydus Lifesciences Mankind Pharma Dr. Reddy'S Labs Aurobindo Pharma
Cash From Operating Activities arrow
1,319.24 2,116.60 3,121.29 5,673.70 5,526.37
Cash Flow from Investing Activities arrow
-371.38 -8,296.10 -196.42 -6,549.30 -3,458.61
Cash from Financing Activities arrow
-1,066.12 5,806.90 -2,952.69 829.00 -1,269.15
Net Cash Inflow / Outflow arrow
-118.26 -372.60 -27.82 -46.60 798.61

Ratios

Profitability Ratios

 Abbott India Zydus Lifesciences Mankind Pharma Dr. Reddy'S Labs Aurobindo Pharma
ROCE (%) arrow
46.72 21.39 13.24 13.75 12.76
ROE (%) arrow
34.67 19.69 12.69 11.69 9.93
ROA (%) arrow
25.08 11.81 7.00 8.03 6.64
EBIT Margin (%) arrow
31.46 33.09 27.88 23.18 21.80
Net Margin (%) arrow
21.50 17.37 13.24 11.86 10.25
Cash Profit Margin (%) arrow
22.95 12.45 18.91 18.45 7.60

Growth Ratios

 Abbott India Zydus Lifesciences Mankind Pharma Dr. Reddy'S Labs Aurobindo Pharma
Revenue Growth (%) arrow
8.11 16.81 16.96 3.24 6.08
EBIT Growth (%) arrow
10.66 22.19 11.92 -19.00 1.85
Net Profit Growth (%) arrow
9.73 8.92 -3.41 -27.38 0.56
EPS Growth (%) arrow
9.73 11.37 -3.97 -25.89 0.54
Book Value Growth (%) arrow
12.93 13.19 13.74 12.99 16.04

Valuation Ratios

 Abbott India Zydus Lifesciences Mankind Pharma Dr. Reddy'S Labs Aurobindo Pharma
Price / Earnings arrow
35.49 17.39 43.29 24.97 21.60
Price / Book Value arrow
11.60 3.23 5.09 2.78 2.00
Dividend Yield (%) arrow
2.53 0.11 0.05 0.64 0.31
EV/EBITDA arrow
24.23 10.91 22.19 13.97 10.02
Market Cap (₹ Cr) arrow
55,086.64 87,643.18 82,801.75 1,04,763.81 75,689.14

Solvency Ratios

 Abbott India Zydus Lifesciences Mankind Pharma Dr. Reddy'S Labs Aurobindo Pharma
Debt to Equity arrow
0.00 0.43 0.37 0.20 0.20
Short term debt to equity ratio arrow
-- 0.16 0.04 0.16 0.16
Current Ratio arrow
2.55 1.27 1.07 1.79 1.81
Quick Ratio arrow
1.91 0.91 0.74 1.34 1.15
Interest Coverage arrow
84.20 16.09 4.62 15.43 14.31

Operating Efficiency Ratios

 Abbott India Zydus Lifesciences Mankind Pharma Dr. Reddy'S Labs Aurobindo Pharma
Debtors to sales (%) arrow
5.22 19.95 12.11 30.04 21.08
Asset Turnover arrow
1.15 1.21 0.54 0.65 1.32
Receivable days arrow
19.09 33.55 39.93 103.79 33.71
Inventory Days arrow
47.06 33.80 51.78 79.94 59.32
Payable days arrow
106.98 149.82 111.46 84.78 148.20
Cash Conversion Cycle arrow
-40.83 -82.46 -19.75 98.95 -55.17
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...